Capital Fund Management S.A. United Therapeutics Corp Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in United Therapeutics Corp stock. As of the latest transaction made, Capital Fund Management S.A. holds 29,654 shares of UTHR stock, worth $10.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

29,654

Previous 23,520 26.08%

Holding current value

$10.8 Million

Previous $7.49 Million 41.83%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $1.91 Million - $2.23 Million	6,134 Added 26.08%	29,654 $10.6 Million
Q2 2024 Aug 13, 2024	BUY	$228.26 - $319.04 $1.17 Million - $1.64 Million	5,131 Added 27.9%	23,520 $7.49 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $3.88 Million - $4.59 Million	18,389 New	18,389 $4.22 Million
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $636,832 - $878,473	-3,643 Reduced 22.08%	12,857 $3.03 Million
Q1 2022 May 12, 2022	BUY	$166.16 - $213.96 $2.74 Million - $3.53 Million	16,500 New	16,500 $2.96 Million
Q4 2021 Feb 10, 2022	SELL	$184.32 - $216.08 $2.32 Million - $2.72 Million	-12,611 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $537,421 - $642,061	-2,988 Reduced 19.16%	12,611 $2.33 Million
Q2 2021 Aug 12, 2021	BUY	$170.47 - $211.93 $483,111 - $600,609	2,834 Added 22.2%	15,599 $2.8 Million
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $1.97 Million - $2.23 Million	12,765 New	12,765 $2.14 Million
Q1 2020 May 13, 2020	SELL	$79.39 - $115.35 $261,987 - $380,655	-3,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$78.31 - $95.34 $258,423 - $314,622	3,300 New	3,300 $291,000
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $6.56 Million - $7.54 Million	-87,669 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$76.06 - $120.81 $6.32 Million - $10 Million	83,089 Added 1814.17%	87,669 $6.84 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $8.92 Million - $10.1 Million	-78,376 Reduced 94.48%	4,580 $586,000
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $2.19 Million - $2.56 Million	-21,648 Reduced 20.7%	82,956 $9.39 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $2.08 Million - $2.95 Million	-19,408 Reduced 15.65%	104,604 $11.8 Million
Q4 2017 Feb 09, 2018	BUY	$118.58 - $151.28 $7.41 Million - $9.46 Million	62,524 Added 101.68%	124,012 $18.3 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $7.05 Million - $8.41 Million	61,488	61,488 $7.21 Million

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. United Therapeutics Corp Transaction History